On the recordJune 11, 2018
This system is opaque, and the incentives are frequently perverse in drug pricing.
Source
congress.govThis system is opaque, and the incentives are frequently perverse in drug pricing.
Collins discusses the complexities and issues in drug pricing systems.
Share
More from Susan Collins
These allegations are appalling. Nevertheless, it is not up to me to choose the Democratic nominee for Senate.
But to be fair to the Department of Homeland Security, they couldn’t enter into contracts when the government was shut down by the Democrats.